- Home
- GMHS vs ALEC Comparison
GMHS vs ALEC Comparison
Compare GMHS & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMHS
- ALEC
- Stock Information
- Founded
- GMHS N/A
- ALEC 2013
- Country
- GMHS China
- ALEC United States
- Employees
- GMHS N/A
- ALEC N/A
- Industry
- GMHS
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GMHS
- ALEC Health Care
- Exchange
- GMHS NYSE
- ALEC Nasdaq
- Market Cap
- GMHS 106.1M
- ALEC 124.0M
- IPO Year
- GMHS N/A
- ALEC 2019
- Fundamental
- Price
- GMHS $1.76
- ALEC $1.32
- Analyst Decision
- GMHS
- ALEC Buy
- Analyst Count
- GMHS 0
- ALEC 7
- Target Price
- GMHS N/A
- ALEC $4.70
- AVG Volume (30 Days)
- GMHS 18.0K
- ALEC 1.2M
- Earning Date
- GMHS 01-01-0001
- ALEC 05-08-2025
- Dividend Yield
- GMHS N/A
- ALEC N/A
- EPS Growth
- GMHS N/A
- ALEC N/A
- EPS
- GMHS 0.03
- ALEC N/A
- Revenue
- GMHS $119,023,021.00
- ALEC $88,339,000.00
- Revenue This Year
- GMHS N/A
- ALEC N/A
- Revenue Next Year
- GMHS N/A
- ALEC $392.45
- P/E Ratio
- GMHS $61.53
- ALEC N/A
- Revenue Growth
- GMHS N/A
- ALEC N/A
- 52 Week Low
- GMHS $0.96
- ALEC $0.87
- 52 Week High
- GMHS $9.00
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- GMHS N/A
- ALEC 55.51
- Support Level
- GMHS N/A
- ALEC $1.01
- Resistance Level
- GMHS N/A
- ALEC $1.46
- Average True Range (ATR)
- GMHS 0.00
- ALEC 0.12
- MACD
- GMHS 0.00
- ALEC 0.02
- Stochastic Oscillator
- GMHS 0.00
- ALEC 71.11
About GMHS GAMEHAUS HOLDINGS INC
Gamehaus Holdings Inc is a technology-driven mobile game publishing company for small- and medium-sized game developers. It built a diverse game portfolio across multiple genres, including social casino, match, simulation, RPG, puzzle, and bingo, others, and distributes mobile games created by developer partners across a wide range of gaming markets, including in countries such as the U.S., the U.K., Australia, Germany, France, Canada, Brazil, Japan, and India, among others. The company offers a comprehensive package of services covering all aspects of the game life cycle, including (i) game development, (ii) screening and pre-publication testing, (iii) user acquisition, and (iv) monetization.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.